WebOct 25, 2024 · Titan Pharmaceuticals, Inc. (NASDAQ:TTNP), based in South San Francisco, CA, is a development stage company developing proprietary therapeutics with its ProNeura ® long-term, continuous drug ... WebTitan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product ...
Titan Pharmaceuticals, Inc. (TTNP) - Stock Analysis
WebTitan Pharmaceuticals, Inc. common stock (TTNP) Stock Price & News - Google Finance Home TTNP • NASDAQ Titan Pharmaceuticals, Inc. common stock Follow Share $0.80 Apr 6, 8:00:00 PM GMT-4 ·... WebDec 21, 2024 · Titan Pharmaceuticals, Inc. (NASDAQ:TTNP), based in South San Francisco, CA, is a development stage company developing proprietary therapeutics with its ProNeura® long-term, continuous drug delivery technology. ald carcinome basocellulaire
Titan Pharmaceuticals (NASDAQ:TTNP) Research Coverage …
WebLegal Name Titan Pharmaceuticals, Inc. Stock Symbol NASDAQ:TTNP Company Type For Profit Contact Email [email protected] Phone Number 6502440715 Titan Pharmaceuticals, Inc. is a biopharmaceutical Company developing proprietary therapeutics primarily for the treatment of serious medical disorders. Titan Pharmaceuticals, Inc. is a development-stage biotechnology company developing proprietary therapeutics using its clinically proven ProNeura® long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions where maintaining consistent, around-the-clock blood levels of med… WebTitan Pharmaceuticals Inc. is developing proprietary therapeutics primarily for the treatment of serious medical disorders. The company's lead product is Probuphine®, the first and only... ald carmarket contatti